1 Min Read
July 7 (Reuters) - Oncolys BioPharma Inc
* Says first patient enrolled into Telomelysin Phase I clinical trial for esophageal cancer treatment
Source text in Japanese:goo.gl/bLnYm8
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.